Charles Newton – Biography
Last update: March 18, 2026Executive profile
Charles was Chief Financial Officer at Lyell Immunopharma, and Director at Carmot Therapeutics. Charles Newton joined Novavax in 2026.
Charles Newton is currentlyBoard Member at Delfi Diagnostics - View - Delfi Diagnostics org chart
Director at Keros Therapeutics - View - Keros Therapeutics org chart
Independent Director at Novavax - View - Novavax org chart
Create your alert
to follow the career of Charles Newton.
Education
Charles Newton has a Bachelor of Science in Finance from Miami University and a Master of Business Administration from Dartmouth College - The Tuck School of Business.
They have also studied at Miami University :
Find more alumni from Miami University
They have also studied at Dartmouth College - The Tuck School of Business :
Find more alumni from Dartmouth College - The Tuck School of Business
More about Charles Newton
Selected links
Do you need to know more about Charles Newton? More results.
Participate
Social media
- Charles Newton on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Charles Newton
The colleagues of Charles Newton
Company Colleagues
- At Delfi Diagnostics, Charles Newton has 19 colleagues including Susan Tousi (CEO & Director), Liz Homans (Chairman of the Board)…
- At Keros Therapeutics, Charles Newton has 15 colleagues including Jasbir Seehra (CEO & Chairman), Nima Farzan (Director)…
- At Novavax, Charles Newton has 35 colleagues including John Jacobs (CEO & President), Rick Rodgers (Director)…
Industry Colleagues
- In the Biotechnology industry, Charles Newton has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Charles Newton.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Charles Newton.
